Suppr超能文献

用减毒小肠结肠炎耶尔森氏菌突变体经口服感染诱导的IgA反应:其作为口服载体疫苗应用的意义

IgA response by oral infection with an attenuated Yersinia enterocolitica mutant: implications for its use as oral carrier vaccine.

作者信息

Blanco Helga M, Lacoste María G, Eliçabe Ricardo J, Di Genaro María S

机构信息

Immunology, Laboratory of Microbiology, Chemistry, Biochemistry and Pharmacy Faculty, National University of San Luis, IMIBIO-SL, CONICET, San Luis, Argentina.

出版信息

Vaccine. 2008 Dec 2;26(51):6497-502. doi: 10.1016/j.vaccine.2008.09.046.

Abstract

Yersinia enterocolitica (Ye) mutant strain (sycH-) is unable to secrete the virulence protein YopH. Mucosal vaccination is often required to induce protection, but stimulating strong IgA response is frequently difficult. Here, we addressed whether Ye sycH- might induce IgA response, and investigated its attenuation in TNFRp55-/-, IL-12p40-/- and IL-4-/- mice. We found that Ye sycH- colonizes Peyer's patches, and induces higher Yersinia-specific IgA levels in feces and in serum compared with Ye wild type. The Ye sycH-mutant proved to be attenuated and induced IgA in both wild-type and immunodeficient mice. These lines of evidence show the attenuation of Ye sycH- and its ability to stimulate an IgA response. This mutant might be useful as an oral vaccine carrier.

摘要

小肠结肠炎耶尔森菌(Ye)突变株(sycH-)无法分泌毒力蛋白YopH。通常需要进行黏膜疫苗接种来诱导保护作用,但刺激产生强烈的IgA反应常常很困难。在此,我们探讨了Ye sycH-是否能诱导IgA反应,并研究了其在TNFRp55-/-、IL-12p40-/-和IL-4-/-小鼠中的减毒情况。我们发现Ye sycH-定殖于派尔集合淋巴结,与Ye野生型相比,其在粪便和血清中诱导产生更高水平的耶尔森菌特异性IgA。Ye sycH-突变株被证明具有减毒作用,并能在野生型和免疫缺陷小鼠中诱导产生IgA。这些证据表明Ye sycH-的减毒作用及其刺激IgA反应的能力。该突变株可能作为口服疫苗载体有用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验